Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Maria Gabriella Matera, Paola Rogliani, Clive P Page, Luigino Calzetta, Mario Cazzol. The discovery and development of gefapixant as a novel antitussive therapy. Expert opinion on drug discovery. 2024-08-14. PMID:39138872. |
however, its adverse effect profile, particularly taste disturbances such as dysgeusia and hypogeusia, the incidence of which is dose-dependent, poses a significant challenge to patient compliance and overall treatment satisfaction. |
2024-08-14 |
2024-08-16 |
Not clear |
Pedada Divya Harika, Komali Garlapati, Raj Kumar Badam, Poojitha Gone, Ayesha Aiman, Hanmandla Rajani, Sri Sahithya Kataram, Mansi Kulkarni, Anulatha Manne, Manogyna Bonth. Taste Changes and Salivary Flow Rate Disparities in Premenopausal and Postmenopausal Women: Exploring the Zinc Connection. Cureus. vol 16. issue 6. 2024-07-18. PMID:39022522. |
menopause triggers hormonal changes that can manifest in oral symptoms like dysgeusia, xerostomia, and burning sensations, substantially impacting daily life, including chewing, swallowing, and taste perception. |
2024-07-18 |
2024-07-20 |
Not clear |
Beatrice Mazzoleni, Giulia Ferrari, Riccardo Caccialanza, Daniela Cattani, Francesca Savioni, Sergio Ferrante, Diego Lopane, Alessandra Dacomi, Chiara Coldani, Giuseppina Tomaiuolo, Giuliano Anastasi, Stefano Manci. Pharmacological strategies and nutritional supplements for managing dysgeusia among chemotherapy patients: A systematic review. Clinical nutrition ESPEN. vol 63. 2024-06-20. PMID:38900642. |
among the side effects of chemotherapy, there is dysgeusia, which is an alteration or damage to the taste perception that negatively impacts the biopsychosocial sphere of the patient. |
2024-06-20 |
2024-06-23 |
Not clear |
Marco Sguanci, Gaetano Ferrara, Sara Morales Palomares, Mauro Parozzi, Lea Godino, Domenica Gazineo, Giuliano Anastasi, Stefano Manci. Dysgeusia and Chronic Kidney Disease: a Scoping Review. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2024-05-10. PMID:38729584. |
dysgeusia, a common altered taste perception in ckd patients, results in reduced taste acuity, impaired salt detection, and a metallic taste sensation, leading to nutritional alterations. |
2024-05-10 |
2024-05-27 |
Not clear |
S C López-Salido, H A Espinoza-Gutiérrez, F E Housni, M E Flores-Soto, J M Viveros-Parede. In health and illness: does taste remain consistent? Exploring the influence of inflammation on taste perception through a systematic review and meta-analysis. European review for medical and pharmacological sciences. vol 28. issue 8. 2024-05-06. PMID:38708467. |
dysgeusia is characterized by a loss of taste perception, leading to malnutrition. |
2024-05-06 |
2024-05-08 |
Not clear |
Makito Miyake, Nobutaka Nishimura, Yuki Oda, Tatsuki Miyamoto, Mitsuru Tomizawa, Takuto Shimizu, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Tomomi Fujii, Nobumichi Tanaka, Kiyohide Fujimot. Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale. Journal of chemotherapy (Florence, Italy). 2024-04-17. PMID:38628149. |
dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale. |
2024-04-17 |
2024-04-19 |
Not clear |
P-G Silva, G-A Barreto, A-C Carlos, M-M Borges, C-E Malta, J-V Barbosa, A-A Crispim, S-F Juaçaba, L-F Gonzaga-Silv. Dysgeusia increases the risk for death and other side effects during antineoplastic systemic treatment for solid tumors: a cross-sectional study. Medicina oral, patologia oral y cirugia bucal. 2024-04-14. PMID:38615256. |
due to its nonspecificity, chemotherapy can cause a series of adverse effects, such as altered taste (dysgeusia), associated with malnutrition and, consequently, other adverse effects in the gastrointestinal tract and increased mortality risk. |
2024-04-14 |
2024-04-16 |
Not clear |
Maurizio G Vento, Caterina Marinelli, Luciano Ferrari, Giuseppe Pedrazz. Recovery of Smell and Taste in Patients With Persistent COVID-19-Related Hyposmia and Dysgeusia by Targeting Inflammation and Endothelial Dysfunction. Cureus. vol 16. issue 2. 2024-03-28. PMID:38544584. |
recovery of smell and taste in patients with persistent covid-19-related hyposmia and dysgeusia by targeting inflammation and endothelial dysfunction. |
2024-03-28 |
2024-03-30 |
Not clear |
Maria Paola Cecchini, Francesca Benedetta Pizzini, Federico Boschi, Alessandro Marcon, Lucia Moro, Elizabeth Gordon, Nicolas Guizard, Enrica Cavedo, Maria Jimena Ricatti, Sheila Veronese, Stefano Tamburin, Michele Tinazzi, Giancarlo Mansueto, Andrea Sbarbat. Long-term effects of SARS-CoV-2 infection in patients with and without chemosensory disorders at disease onset: a psychophysical and magnetic resonance imaging exploratory study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2024-03-05. PMID:38441790. |
no significant differences emerged comparing taste scores between group 1 and group 2, but dysgeusia was only present in group 1 patients. |
2024-03-05 |
2024-03-07 |
human |
Mariano Mastinu, Lisa Sophie Grzeschuchna, Coralie Mignot, Cagdas Guducu, Vasyl Bogdanov, Thomas Humme. Time-frequency analysis of gustatory event related potentials (gERP) in taste disorders. Scientific reports. vol 14. issue 1. 2024-01-30. PMID:38291123. |
this study included 44 patients with dysgeusia and 59 healthy participants, who underwent a comprehensive clinical examination of gustatory function. |
2024-01-30 |
2024-02-02 |
human |
Mariano Mastinu, Lisa Sophie Grzeschuchna, Coralie Mignot, Cagdas Guducu, Vasyl Bogdanov, Thomas Humme. Time-frequency analysis of gustatory event related potentials (gERP) in taste disorders. Scientific reports. vol 14. issue 1. 2024-01-30. PMID:38291123. |
hence, gerps reflect the altered taste sensation in patients with dysgeusia. |
2024-01-30 |
2024-02-02 |
human |
A M G A Laheij, N W C J van de Don. Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. vol 32. issue 1. 2023-12-13. PMID:38092979. |
rapidly after the start of talquetamab treatment, patients reported taste changes (dysgeusia; 60% of patients), and a feeling of dry mouth (xerostomia; 30-57% of patients), which may be related to expression of the target antigen in healthy tissues, such as taste buds. |
2023-12-13 |
2023-12-17 |
Not clear |
Si-Yu Chu, Huang-Chi Wang, Ming-Hong Hsieh, Cheng-Chen Chan. Taste Disorder and Tongue Numbness After Lithium Overdose. Acta neurologica Taiwanica. vol 33(4). 2023-12-01. PMID:38030229. |
drug-induced taste disturbances are prevalent in clinical practice, with dysgeusia being a frequent manifestation. |
2023-12-01 |
2023-12-10 |
Not clear |
Anna Irene Vedel Sørensen, Lampros Spiliopoulos, Peter Bager, Nete Munk Nielsen, Jørgen Vinsløv Hansen, Anders Koch, Inger Kristine Meder, Anders Hviid, Steen Ethelber. A Danish questionnaire study of acute symptoms of SARS-CoV-2 infection by variant, vaccination status, sex and age. Scientific reports. vol 13. issue 1. 2023-11-14. PMID:37964010. |
rds for altered sense of smell (dysosmia) and taste (dysgeusia) were highest for delta (rd = 50.8 (49.4-52.0) and rd = 54.7 (53.4-56.0), respectively) and lowest for omicron (rd = 12.8 (12.1-13.5) and rd = 11.8 (11.1-12.4), respectively). |
2023-11-14 |
2023-11-20 |
human |
Lauren Caronia, Ranhui Xi, Robert F Margolskee, Peihua Jian. Paxlovid mouth likely is mediated by activation of the TAS2R1 bitter receptor by nirmatrelvir. Biochemical and biophysical research communications. vol 682. 2023-10-08. PMID:37806252. |
consistent with this, dysgeusia (altered taste) is listed as a main adverse effect of paxlovid based on clinical trial data. |
2023-10-08 |
2023-10-15 |
Not clear |
D A Cerbon, C S Seldon Taswell, G Azzam, F Yang, R Carmona, M C Abramowitz, M A Samuels, G J Kubicek, L M Freedman, S Samuel. Dosimetric Parameters Correlate with Taste Alterations in Head and Neck Radiotherapy. International journal of radiation oncology, biology, physics. vol 117. issue 2S. 2023-10-03. PMID:37784901. |
dysgeusia is an acute and chronic side effect of head and neck chemoradiation, with persistent taste dysfunction 1-2 years post radiotherapy occurring in 23-50% of patients. |
2023-10-03 |
2023-10-07 |
Not clear |
J Wang, R Liu, H Ma, W Zhan. The Pathogenesis of COVID-19-Related Taste Disorder and Treatments. Journal of dental research. 2023-09-20. PMID:37729625. |
in dysgeusia, the differentiation of taste bud stem cells can be stimulated through exogenous epithelial-derived and neural-derived factors to regenerate taste buds. |
2023-09-20 |
2023-10-07 |
Not clear |
J Wang, R Liu, H Ma, W Zhan. The Pathogenesis of COVID-19-Related Taste Disorder and Treatments. Journal of dental research. 2023-09-20. PMID:37729625. |
this review presents the current evidence of the pathogenesis of covid-19-related dysgeusia, summarizes currently available treatments, and suggests future directions of taste regeneration therapy. |
2023-09-20 |
2023-10-07 |
Not clear |
Fabio Busato, Davide Fiorentin, Andrea Bettinelli, Giuseppe Anile, Maria Grazia Ghi, Alessandro Scaggion, Francesca Dusi, Marta Paiusco, Marco Ferrari, Piero Nicolai, Francesca Marturan. Dosiomic-based prediction of dysgeusia in head & neck cancer patients treated with radiotherapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2023-09-03. PMID:37660751. |
to investigate the potential of dosiomics in predicting radiotherapy-induced taste distortion (dysgeusia) in head & neck (h&n) cancer. |
2023-09-03 |
2023-09-07 |
Not clear |
Arun Kalava, Steven A Benyahia, Ramon Tico Calzada, Christine M Staa. Efficacy of Stellate Ganglion Block in Treating Long-Term COVID-19-Related Olfactory and Gustatory Dysfunction: A Case Series. Cureus. vol 15. issue 6. 2023-07-27. PMID:37496529. |
olfactory and gustatory dysfunction, including anosmia, parosmia, ageusia, and dysgeusia, are common long-term symptoms of coronavirus disease 2019 (covid-19) infection. |
2023-07-27 |
2023-08-14 |
Not clear |